Bank of America Securities analyst Lyanne Harrison reiterated a Buy rating on Resmed (RMD – Research Report) today and set a price target of $270.00. Lyanne Harrison’s rating is based on the ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...